Skip to content

ROSA Total Knee Investigational Testing Authorization Study

ROSA Total Knee Investigational Testing Authorization Study: Prospective Single Center Study of the ROSA Total Knee System

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03970629
Enrollment
19
Registered
2019-05-31
Start date
2019-06-20
Completion date
2021-11-23
Last updated
2022-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis of Femoral Condyle, Chronic Osteoarthritis, Knee Pain, Moderate Varus, Valgus or Flexion Deformities, Rheumatoid Arthritis

Brief summary

This is a prospective, single-center clinical study designed to facilitate the collection and evaluation of workflow efficiency, patient pain and function, and adverse event data. This clinical study will include Persona Total Knee components using the ROSA Total Knee Robotic System or conventional instrumentation.

Detailed description

The primary objective of this study is to collect and compare clinical outcomes and surgical data using the ROSA Total Knee robotic instrumentation and conventional instrumentation in primary total knee arthroplasty. The assessments will include: Planned vs actual component positioning; Workflow efficiency; Patient safety based on incidence and frequency of adverse events; Clinical performance measured by overall pain and function, quality of life data, and radiographic parameters.

Interventions

Primary Total Knee Arthroplasty

Sponsors

Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patient is a minimum of 18 years of age 2. Pre-op component positioning and sizing plan prior to surgery 3. Independent of study participation, patient is a candidate for primary TKA using the commercially available Persona knee components implanted in accordance with product labeling 4. Patient has participated in this study-related Informed Consent process 5. Patient is willing and able to provide written Informed Consent by signing and dating the IRB or EC approved Informed Consent form 6. Patient is willing and able to complete scheduled study procedures and follow-up evaluations

Exclusion criteria

1. Patient is currently participating in any other surgical intervention studies or pain management studies 2. Patient has underwent contralateral UKA or TKA within the last 18 months 3. Hip pathology with significant bone loss (e.g. avascular necrosis of the femoral head with collapse, severe dysplasia of the femoral head or the acetabulum) 4. Hip pathology severely limiting range of motion (e.g. arthrodesis, severe contracture, chronic severe dislocation) 5. Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.) 6. Patient has previously received partial or total knee arthroplasty for the ipsilateral knee

Design outcomes

Primary

MeasureTime frameDescription
EQ-5D questionnaire1 yearEQ-5D
Oxford Knee Score Questionnaire1 yearOxford Knee Score

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026